Taro Pharmaceuticals (United States)

Bioanalytical Method Validation—A Revisit with a Decade of Progress

Vinod P. Shah, Kamal K. Midha, John W. A. Findlay et al. · Pharmaceutical Research · 2000 · 1.6K citations

Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group

Mercedes Lobera, Kevin P. Madauss, Denise Teotico Pohlhaus et al. · Nature Chemical Biology · 2013 · 368 citations

Histone Modifications, Chromatin, Nonchelating Zinc-binding Group +9

Bioequivalence of Topical Dermatological Dosage Forms-Methods of Evaluation of Bioequivalence

Vinod P. Shah, Gordon L. Flynn, Avraham Yacobi et al. · Pharmaceutical Research · 1998 · 157 citations

The Sensitivity and Specificity of Potassium Hydroxide Smear and Fungal Culture Relative to Clinical Assessment in the Evaluation of Tinea Pedis: A Pooled Analysis

J. Levitt, Barrie Levitt, Arash Akhavan et al. · Dermatology Research and Practice · 2010 · 62 citations · Full text

Diagnostic Mycology, Antifungal Agent, Antifungal Agents +12

Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices

Jennifer Miller, Joseph S. Ross, Marc Wilenzick et al. · BMJ · 2019 · 60 citations · Full text